Product Images Temozolomide

This is a description of Temozolomide Capsules, USP, which are intended for oral administration. The package contains 14 individual sachets, each containing one capsule with 100mg of Temozolomide per capsule. The drug is labeled as hazardous and must be swallowed whole; if a capsule is damaged, contact with skin, eyes, or nose must be avoided. The recommended storage temperature is 25°C with excursions permitted to 15-30°C. Additional instructions and prescribing information should be followed carefully.*

This is a description of Temozolomide capsules, USP for oral administration. Each sachet contains one capsule, with each capsule containing 140 mg of Temozolomide. The packaging contains 14 individual sachets. It is a hazardous drug and should not be opened but swallowed whole. The recommended dosage should be followed as per the prescribing information. It is advised not to come into contact with damaged capsules. The medicine should be stored at 25°C with excursions permitted to 15-30°C. The text also mentions the manufacturer information.*

This text provides information about a medication called Temozolomide, with each capsule containing 180mg of the active ingredient. The capsules are intended for oral administration and should not be opened but swallowed whole. The medication is classified as a hazardous drug and should be stored at 25°C. The text also mentions that the package contains 14 individual sachets, with each sachet containing one capsule. Additionally, it includes a warning to avoid contact with the skin, eyes, or nose if a capsule is damaged.*

This is information about Temozolomide capsules in 100 mg strength distributed by NextSource Pharma in Pompano Beach, FL, USA. The label also includes a warning about it being a hazardous drug and advises to read accompanying directions carefully before use.*

This is a prescription medication called Temozolomide in capsule form. It is distributed by NextSource Pharma in Pompano Beach, FL, USA. The text also includes a warning stating that it is a hazardous drug, and advises reading the accompanying directions carefully before use. It is intended for oral use.*

This description is not available.*

This description is not available.*

This is a Kaplan-Meier curve depicting the overall survival in patients with newly diagnosed Glioblastoma in the MK-7365-051 study. The graph shows the percentage of overall survival over time in months for two treatment groups: RT-TMZ and RT Only. The number at risk is provided for each time point.*